Global estimates of cancer prevalence for 27 sites in the adult population in 2008

International Journal of Cancer

Volumn 132, Issue 5, 2013, Pages 1133-1145

  Bray, Freddie ^a   Ren, Jian Song ^a,b   Masuyer, Eric ^a   Ferlay, Jacques ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

development; healthcare facilities; neoplasms; prevalence; survival

Indexed keywords

ADULT; AFRICA; ARTICLE; ASIA; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVALENCE; CHINA; CONTROLLED STUDY; DEVELOPED COUNTRY; EPIDEMIOLOGICAL DATA; EUROPE; FEMALE; HUMAN; INDIA; KAPOSI SARCOMA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NORTH AMERICA; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; TREATMENT PLANNING; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; SURVIVAL RATE; WORLD HEALTH; YOUNG ADULT;

EID: 84872853140     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27711     Document Type: Article

References (30)

1. Giles G,. How important are estimates of cancer prevalence? Ann Oncol 2002; 13: 815-16.
2. Capocaccia R, Colonna M, Corazziari I, et al. Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol 2002; 13: 831-9.
3. Colonna M, Danzon A, Delafosse P, et al. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. Eur J Cancer 2008; 44: 115-22.
4. Maddams J, Brewster D, Gavin A, et al. Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer 2009; 101: 541-7.
5. AIRTUM Working Group. Italian cancer figures, report 2010: cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. Epidemiol Prev 2010; 34 Suppl 2 (): 1-188.
6. Tabata N, Ohno Y, Matsui R, et al. Partial cancer prevalence in Japan up to 2020: estimates based on incidence and survival data from population-based cancer registries. Jpn J Clin Oncol 2008; 38: 146-57.
7. Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 2011; 43: 1-11.
8. Pisani P, Bray F, Parkin DM,. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97: 72-81.
9. Parkin DM, Bray FI, Devesa SS,. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl 8): S4-S66.
10. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
11. United Nations Development Programme. Human Development Report 2009: overcoming barriers: human mobility and development. 2009.
12. Engholm G, Ferlay J, Christensen N, et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010; 49: 725-36.
13. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
14. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010; 11: 165-73.
15. Swaminathan R, Lucas E, Sankaranarayanan R,. Cancer survival in Africa, Asia, the Caribbean and Central America: database and attributes. IARC Sci Publ 2011; 162: 23-31.
16. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007; 8: 773-83.
17. Verdecchia A, De Angelis G, Capocaccia R,. Estimation and projections of cancer prevalence from cancer registry data. Stat Med 2002; 21: 3511-26.
18. Carpenter WR, Yeh WS, Wobker SE, et al. Getting cancer prevalence right: using state cancer registry data to estimate cancer survivors. Cancer Causes Control 2011; 22: 765-73.
19. Merrill RM, Capocaccia R, Feuer EJ, et al. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol 2000; 29: 197-207.
20. Louchini R, Beaupre M, Demers AA, et al. Trends in cancer prevalence in Quebec. Chronic Dis Can 2006; 27: 110-19.
21. De Angelis R, Tavilla A, Verdecchia A, et al. Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015. Cancer 2009; 115: 1954-66.
22. Kruijshaar ME, Barendregt JJ, Van De Poll-Franse LV,. Estimating the prevalence of breast cancer using a disease model: data problems and trends. Popul Health Metr 2003; 1: 5.
23. Mariotto AB, Rowland JH, Ries LA, et al. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 2007; 16: 566-71.
24. Colonna M, Grosclaude P, Launoy G, et al. Estimation of colorectal cancer prevalence in France. Eur J Cancer 2001; 37: 93-6.
25. Brenner H, Hakulinen T,. Are patients diagnosed with breast cancer before age 50 years ever cured? J Clin Oncol 2004; 22: 432-8.
26. Brenner H, Hakulinen T,. Long-term survival and cure of patients diagnosed with breast cancer before age 50 years. J Clin Oncol 2005; 23: 1585.
27. Soerjomataram I, Lortet-Tieulent J, Ferlay J, Mathers C, Parkin DM, Forman D, Bray F., Disability-adjusted life years: country-specific estimates for 27 cancers in 12 world regions. The Lancet, in press.
28. Soerjomataram I, Lortet-Tieulent J, Ferlay J, Forman D, Mathers C, Parkin DM, Bray F., Estimating and validating disability-adjusted life years at the global level: a framework for cancer. BMC Research Methodology, in press.
29. Mariotto A, Warren JL, Knopf KB, et al. The prevalence of patients with colorectal carcinoma under care in the U.S. Cancer 2003; 98: 1253-61.
30. Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103: 117-28.